Devices › Occluder, patent ductus, arteriosus
Device brand name · Occluder patent ductus arteriosus
Amplatzer Piccolo: medical device reports filed with FDA
220 reports name it, 2022–2026. Manufacturer given most often on reports: Abbott Medical. Product code MAE.
- 220
- device reports naming the brand
- 0% of all MAUDE reports · about 51 a year
- 56
- reports, 12 months to August 2026
- 53 in the 12 months before
- 19.1%
- classified as malfunction
- 33.5% across the product code
- 13.6%
- classified as death, as reported
- 30 reports · not verified by FDA
FDA's MAUDE database holds 220 reports that name the brand "Amplatzer Piccolo" (occluder patent ductus arteriosus), received between March 2022 and August 2026; the manufacturer given most often on reports is Abbott Medical. Spellings of one product vary from report to report.
56 reports arrived in the 12 months to August 2026, close to the 53 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (67.3%), malfunction (19.1%) and death (13.6%); across all occluder, patent ductus, arteriosus reports (product code MAE) death is recorded in 5.7% and malfunction in 33.5%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are migration or expulsion of device (54.1%), patient device interaction problem (13.6%) and improper or incorrect procedure or method (9.5%). The patient problems coded most often are obstruction/occlusion, low blood pressure/ hypotension and tricuspid valve insufficiency/ regurgitation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 1,091 reports carrying product code MAE. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Migration or expulsion of device | 119 | 54.1% | 34.5% |
| Patient device interaction problem | 30 | 13.6% | 8.7% |
| Improper or incorrect procedure or method | 21 | 9.5% | 5.2% |
| Difficult to fold, unfold or collapse | 16 | 7.3% | 19.2% |
| Premature separation | 8 | 3.6% | 1.1% |
| Malposition of device | 7 | 3.2% | 2.6% |
| Patient-device incompatibilitythe device did not suit the patient | 6 | 2.7% | 1.6% |
| Separation problem | 4 | 1.8% | 0.4% |
| Off-label use | 3 | 1.4% | 6.5% |
| Device difficult to setup or prepare | 1 | 0.5% | 0.3% |
| Fluid/blood leak | 1 | 0.5% | 0.1% |
| Fracturea broken bone | 1 | 0.5% | 0.4% |
| Inaccurate information | 1 | 0.5% | 0.1% |
| Migrationthe device moved from where it was placed | 1 | 0.5% | 1.8% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Obstruction/occlusion | 56 | 25.5% |
| Low blood pressure/ hypotension | 12 | 5.5% |
| Tricuspid valve insufficiency/ regurgitation | 12 | 5.5% |
| Sepsisa severe body-wide response to infection | 11 | 5% |
| Hypoxialow oxygen | 10 | 4.5% |
| Thrombosis/thrombus | 10 | 4.5% |
| Respiratory insufficiency | 8 | 3.6% |
| Hemorrhage/blood loss/bleeding | 7 | 3.2% |
| High blood pressure/ hypertension | 7 | 3.2% |
| Arrhythmia | 6 | 2.7% |
| Bradycardiaslow heart rate | 6 | 2.7% |
| Heart failure/congestive heart failure | 6 | 2.7% |
| Pericardial effusionfluid around the heart | 6 | 2.7% |
| Coronary obstruction/occlusion | 5 | 2.3% |
| Aortic valve stenosis | 4 | 1.8% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Amplatzer Piccolo | Product code MAE | All MAUDE reports |
|---|---|---|---|
| Reports | 220 | 1,091 | 26,136,888 |
| Share of that pool | — | 20.2% | 0% |
| Classified as death, per 1,000 reports | 136 | 57 | 9 |
| Classified as injury | 67.3% | 60.6% | 36.2% |
| Classified as malfunction | 19.1% | 33.5% | 62.3% |
| Filed by the manufacturer | 99.5% | 97.4% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code MAE
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Amplatzer Duct Occluder | 513 | 83 | 2.1% |
| Amplatzer Septal Occluder | 3,495 | 406 | 2.4% |
| Amplatzer Cribriform Occluder | 279 | 0 | 0.4% |
| Amplatzer PFO Occluder | 598 | 42 | 2.8% |
| Ipump Pain Management System | 1,018 | 0 | 0.5% |
| Malleable Penile Prosthesis | 290 | 0 | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Amplatzer Piccolo reports
How many FDA reports name Amplatzer Piccolo?
220 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 56 in the latest 12 months.
What kinds of events are reported?
injury (67.3%), malfunction (19.1%) and death (13.6%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
migration or expulsion of device (54.1%), patient device interaction problem (13.6%), improper or incorrect procedure or method (9.5%), difficult to fold, unfold or collapse (7.3%) and premature separation (3.6%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (99.5%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Amplatzer Piccolo was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.